.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
McKinsey
Argus Health
Daiichi Sankyo
Boehringer Ingelheim
Novartis
Merck
Queensland Health
Fuji
Covington

Generated: June 29, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071111

« Back to Dashboard
NDA 071111 describes AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, which is a drug marketed by Mylan, Barr, Watson Labs, Sandoz, and Teva, and is included in five NDAs. It is available from four suppliers. Additional details are available on the AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE profile page.

The generic ingredient in AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is amiloride hydrochloride; hydrochlorothiazide. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the amiloride hydrochloride; hydrochlorothiazide profile page.

Summary for NDA: 071111

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 071111

Suppliers and Packaging for NDA: 071111

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
amiloride hydrochloride; hydrochlorothiazide
TABLET;ORAL 071111 ANDA Teva Pharmaceuticals USA, Inc. 0555-0483 0555-0483-02 100 TABLET in 1 BOTTLE (0555-0483-02)
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
amiloride hydrochloride; hydrochlorothiazide
TABLET;ORAL 071111 ANDA Teva Pharmaceuticals USA, Inc. 0555-0483 0555-0483-05 1000 TABLET in 1 BOTTLE (0555-0483-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG ANHYDROUS;50MG
Approval Date:May 10, 1988TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Cerilliant
AstraZeneca
Accenture
US Department of Justice
Covington
Teva
Fish and Richardson
Novartis
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot